Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 109
Filter
1.
Genome Med ; 12(1): 18, 2020 02 19.
Article in English | MEDLINE | ID: mdl-32075696

ABSTRACT

The European Union (EU) initiative on the Digital Transformation of Health and Care (Digicare) aims to provide the conditions necessary for building a secure, flexible, and decentralized digital health infrastructure. Creating a European Health Research and Innovation Cloud (HRIC) within this environment should enable data sharing and analysis for health research across the EU, in compliance with data protection legislation while preserving the full trust of the participants. Such a HRIC should learn from and build on existing data infrastructures, integrate best practices, and focus on the concrete needs of the community in terms of technologies, governance, management, regulation, and ethics requirements. Here, we describe the vision and expected benefits of digital data sharing in health research activities and present a roadmap that fosters the opportunities while answering the challenges of implementing a HRIC. For this, we put forward five specific recommendations and action points to ensure that a European HRIC: i) is built on established standards and guidelines, providing cloud technologies through an open and decentralized infrastructure; ii) is developed and certified to the highest standards of interoperability and data security that can be trusted by all stakeholders; iii) is supported by a robust ethical and legal framework that is compliant with the EU General Data Protection Regulation (GDPR); iv) establishes a proper environment for the training of new generations of data and medical scientists; and v) stimulates research and innovation in transnational collaborations through public and private initiatives and partnerships funded by the EU through Horizon 2020 and Horizon Europe.


Subject(s)
Biomedical Research/organization & administration , Cloud Computing , Diffusion of Innovation , Practice Guidelines as Topic , Biomedical Research/methods , European Union , Information Dissemination/legislation & jurisprudence , Information Dissemination/methods
2.
Sci Rep ; 10(1): 1569, 2020 01 31.
Article in English | MEDLINE | ID: mdl-32005875

ABSTRACT

Mitochondrial dysfunction is a hallmark in idiopathic Parkinson's disease (IPD). Here, we established screenable phenotypes of mitochondrial morphology and function in primary fibroblasts derived from patients with IPD. Upper arm punch skin biopsy was performed in 41 patients with mid-stage IPD and 21 age-matched healthy controls. At the single-cell level, the basal mitochondrial membrane potential (Ψm) was higher in patients with IPD than in controls. Similarly, under carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) stress, the remaining Ψm was increased in patients with IPD. Analysis of mitochondrial morphometric parameters revealed significantly decreased mitochondrial connectivity in patients with IPD, with 9 of 14 morphometric mitochondrial parameters differing from those in controls. Significant morphometric mitochondrial changes included the node degree, mean volume, skeleton size, perimeter, form factor, node count, erosion body count, endpoints, and mitochondria count (all P-values < 0.05). These functional data reveal that resistance to depolarization was increased by treatment with the protonophore FCCP in patients with IPD, whereas morphometric data revealed decreased mitochondrial connectivity and increased mitochondrial fragmentation.


Subject(s)
Membrane Potential, Mitochondrial/physiology , Mitochondria/pathology , Parkinson Disease/pathology , Aged , Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone/pharmacology , Case-Control Studies , Female , Fibroblasts/physiology , Humans , Male , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/physiology , Parkinson Disease/physiopathology
3.
J Biomol Screen ; 21(5): 496-509, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26738520

ABSTRACT

The immortalized and proliferative cell line SH-SY5Y is one of the most commonly used cell lines in neuroscience and neuroblastoma research. However, undifferentiated SH-SY5Y cells share few properties with mature neurons. In this study, we present an optimized neuronal differentiation protocol for SH-SY5Y that requires only two work steps and 6 days. After differentiation, the cells present increased levels of ATP and plasma membrane activity but reduced expression of energetic stress response genes. Differentiation results in reduced mitochondrial membrane potential and decreased robustness toward perturbations with 6-hydroxydopamine. We are convinced that the presented differentiation method will leverage genetic and chemical high-throughput screening projects targeting pathways that are involved in the selective vulnerability of neurons with high energetic stress levels.


Subject(s)
Cell Culture Techniques/methods , Cell Differentiation/genetics , Neurons/metabolism , Oxidative Stress/genetics , Adenosine Triphosphate/genetics , Cell Membrane/genetics , Cell Proliferation/genetics , Humans , Membrane Potential, Mitochondrial/genetics , Neurons/pathology
4.
Curr Mol Med ; 10(6): 533-9, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20642442

ABSTRACT

FOXP3 is essential for the development and function of regulatory CD4(+)CD25(hi) T (T(reg)) cells. However, recent evidence suggests that FOXP3 alone is not sufficient to completely explain the regulatory phenotype of these key players in autoimmunity and inflammation: after being activated, conventional human CD4(+) T cells transiently up-regulate FOXP3 without acquiring a regulatory function. Researchers have recently found that glycoprotein A repetitions predominant (GARP, or LRRC32) is a T(reg)-specific receptor that binds latent TGF-beta and dominantly controls FOXP3 and the regulatory phenotype via a positive feedback loop. This finding provides a missing link in our molecular understanding of FOXP3 in T(reg) cells. This viewpoint focuses on GARP as safeguard of FOXP3 and the regulatory phenotype.


Subject(s)
Forkhead Transcription Factors/metabolism , Membrane Proteins/metabolism , Animals , Forkhead Transcription Factors/genetics , Humans , Membrane Proteins/genetics , Models, Biological , T-Lymphocytes, Regulatory/metabolism , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism
5.
J Cell Mol Med ; 13(9B): 3343-57, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19453521

ABSTRACT

Recent evidence suggests that regulatory pathways might control sustained high levels of FOXP3 in regulatory CD4(+)CD25(hi) T (T(reg)) cells. Based on transcriptional profiling of ex vivo activated T(reg) and helper CD4(+)CD25(-) T (T(h)) cells we have identified GARP (glycoprotein-A repetitions predominant), LGALS3 (lectin, galactoside-binding, soluble, 3) and LGMN (legumain) as novel genes implicated in human T(reg) cell function, which are induced upon T-cell receptor stimulation. Retroviral overexpression of GARP in antigen-specific T(h) cells leads to an efficient and stable re-programming of an effector T cell towards a regulatory T cell, which involves up-regulation of FOXP3, LGALS3, LGMN and other T(reg)-associated markers. In contrast, overexpression of LGALS3 and LGMN enhance FOXP3 and GARP expression, but only partially induced a regulatory phenotype. Lentiviral down-regulation of GARP in T(reg) cells significantly impaired the suppressor function and was associated with down-regulation of FOXP3. Moreover, down-regulation of FOXP3 resulted in similar phenotypic changes and down-regulation of GARP. This provides compelling evidence for a GARP-FOXP3 positive feedback loop and provides a rational molecular basis for the known difference between natural and transforming growth factor-beta induced T(reg) cells as we show here that the latter do not up-regulate GARP. In summary, we have identified GARP as a key receptor controlling FOXP3 in T(reg) cells following T-cell activation in a positive feedback loop assisted by LGALS3 and LGMN, which represents a promising new system for the therapeutic manipulation of T cells in human disease.


Subject(s)
Forkhead Transcription Factors/metabolism , Gene Expression Regulation , Membrane Proteins/metabolism , T-Lymphocytes, Regulatory/cytology , CD4-Positive T-Lymphocytes/cytology , Culture Media/metabolism , Down-Regulation , Green Fluorescent Proteins/chemistry , Humans , Interleukin-2 Receptor alpha Subunit/biosynthesis , Ionomycin/pharmacology , Models, Biological , Phenotype , Signal Transduction , Transcription, Genetic
6.
Methods Inf Med ; 47(4): 296-317, 2008.
Article in English | MEDLINE | ID: mdl-18690363

ABSTRACT

OBJECTIVE: To discuss interdisciplinary research and education in the context of informatics and medicine by commenting on the paper of Kuhn et al. "Informatics and Medicine: From Molecules to Populations". METHOD: Inviting an international group of experts in biomedical and health informatics and related disciplines to comment on this paper. RESULTS AND CONCLUSIONS: The commentaries include a wide range of reasoned arguments and original position statements which, while strongly endorsing the educational needs identified by Kuhn et al., also point out fundamental challenges that are very specific to the unusual combination of scientific, technological, personal and social problems characterizing biomedical informatics. They point to the ultimate objectives of managing difficult human health problems, which are unlikely to yield to technological solutions alone. The psychological, societal, and environmental components of health and disease are emphasized by several of the commentators, setting the stage for further debate and constructive suggestions.


Subject(s)
Medical Informatics , Peer Review , Public Health Informatics , Research
7.
Birth Defects Res B Dev Reprod Toxicol ; 80(6): 425-50, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18157899

ABSTRACT

Skeletal variations are common in humans, and potentially are caused by genetic as well as environmental factors. We here review molecular principles in skeletal development to develop a knowledge base of possible alterations that could explain variations in skeletal element number, shape or size. Environmental agents that induce variations, such as teratogens, likely interact with the molecular pathways that regulate skeletal development.


Subject(s)
Abnormalities, Drug-Induced/genetics , Bone Development/genetics , Bone and Bones/abnormalities , Animals , Bone Development/drug effects , Gene Expression Regulation, Developmental/physiology , Mice , Teratogens/toxicity
8.
Infect Immun ; 70(9): 5202-7, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12183571

ABSTRACT

Caenorhabditis elegans is currently introduced as a new, facile, and cheap model organism to study the pathogenesis of gram-negative bacteria such as Pseudomonas aeruginosa and Salmonella enterica serovar Typhimurium. The mechanisms of killing involve either diffusible exotoxins or infection-like processes. Recently, it was shown that also some gram-positive bacteria kill C. elegans, although the precise mechanisms of killing remained open. We examined C. elegans as a pathogenesis model for the gram-positive bacterium Streptococcus pyogenes, a major human pathogen capable of causing a wide spectrum of diseases. We demonstrate that S. pyogenes kills C. elegans, both on solid and in liquid medium. Unlike P. aeruginosa and S. enterica serovar Typhimurium, the killing by S. pyogenes is solely mediated by hydrogen peroxide. Killing required live streptococci; the killing capacity depends on the amount of hydrogen peroxide produced, and killing can be inhibited by catalase. Major exotoxins of S. pyogenes are not involved in the killing process as confirmed by using specific toxin inhibitors and knockout mutants. Moreover, no accumulation of S. pyogenes in C. elegans is observed, which excludes the involvement of infection-like processes. Preliminary results show that S. pneumoniae can also kill C. elegans by hydrogen peroxide production. Hydrogen peroxide-mediated killing might represent a common mechanism by which gram-positive, catalase-negative pathogens kill C. elegans.


Subject(s)
Bacterial Proteins , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/microbiology , Hydrogen Peroxide/metabolism , Hydrogen Peroxide/toxicity , Membrane Proteins , Streptococcus pyogenes/metabolism , Streptococcus pyogenes/pathogenicity , Animals , Bacterial Toxins/toxicity , Exotoxins/toxicity , Models, Animal , Virulence/physiology
9.
Acta Physiol Scand ; 174(4): 367-75, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11942924

ABSTRACT

To assess the contribution of genetic background to respiratory mechanics, we developed a ventilator unit to measure lung function parameters in the mouse. We studied two commonly used inbred mice strains originating from Mus musculus domesticus (C57BL/6 and C3HeB/FeJ) and a third strain derived from Mus musculus molossinus [Japanese fancy mouse 1 (JF1)]. The ventilator allows for accurate performance of the different breathing manoeuvres required for measuring in- and expiratory reserve capacity, quasi-static and dynamic compliance, and airway resistance. In combination with a mass spectrometer for monitoring gas concentrations, single-breath manoeuvres were performed and He-expirograms obtained, from which dead space volume and slope of phase III were determined. From each strain and each sex, 10, 2-month old animals were studied immediately after being killed by an intraperitoneal overdose of xylazine and ketamine. C3HeB/FeJ and C57BL/6 exhibited comparable lung volumes. In male C3HeB/FeJ mice, e.g. vital capacity (VC) was 1072 +/- 79 microL, inspiratory reserve capacity 782 +/- 88 microL, and dead space volume at total lung inflation 216 +/- 18 microL. Lung volumes of JF1 were significantly lower (e.g. VC 611 +/- 53 microL, P < 0.01) even when normalized to body weight. In all three strains, specific lung volumes were significantly higher in females than in males, possibly explained by a higher oxygen demand during pregnancy and lactation, both of which fill most of their life times. Static compliance in C3HeB/FeJ was 64.3 +/- 5.4 microL cmH2O-1. It was smaller in C57BL/6 and JF1 mice, even when related to the lung volume. Analysis of the degree of genetic vs. non-genetic components of the phenotypic variation revealed that at least 80% of the total variation of lung volumes and static compliance in the mixed population is attributable to genetic differences between individuals. These differences will be verified in further studies by segregation and genetic linkage analysis.


Subject(s)
Lung/physiology , Respiratory Mechanics/genetics , Sex Characteristics , Animals , Female , Lung Volume Measurements/instrumentation , Male , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Phenotype , Reproducibility of Results , Species Specificity , Total Lung Capacity/physiology
10.
Article in English | MEDLINE | ID: mdl-11701658

ABSTRACT

With the completion of the human genome, sequence analysis of gene function will move into the center of future genome research. One of the key strategies for studying gene function involves the genetic dissection of biological processes in animal models. Mouse mutants are of particular importance for the analysis of disease pathogenesis and transgenic techniques, and gene targeting have become routine tools. Recently, phenotype-driven strategies using chemical mutagenesis have been the target of increasing interest. In this review, the current state of ENU mutagenesis and its application as a systematic tool of genome analysis are examined.


Subject(s)
Ethylnitrosourea/toxicity , Mutagens/toxicity , Animals , Genes, Dominant , Genes, Recessive , Genotype , Information Management , Mice , Mutagenesis , Phenotype
11.
Invest Ophthalmol Vis Sci ; 42(12): 2909-15, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11687536

ABSTRACT

PURPOSE: During an ethylnitrosourea (ENU) mutagenesis screening, mice were tested for the occurrence of dominant cataracts. The purpose of the study was morphologic description, mapping of the mutant gene, and characterization of the underlying molecular lesion in a particular mutant, Aey7. METHODS: Isolated lenses were photographed and histologic sections of the eye were analyzed according to standard procedures. Linkage analysis was performed with a set of microsatellite markers covering all autosomal chromosomes. cDNA was amplified after reverse transcription of lens mRNA. For PCR, cDNA or genomic DNA was used as a template. RESULTS: Nuclear opacity and posterior suture anomaly were visible at eye opening and progressed to a nuclear and zonular cataract at 2 months of age. The opacity as well as the microphthalmia was more pronounced in the homozygotes than in the heterozygotes. The mutation was mapped to chromosome 17 between the markers D17Mit133 and D17Mit180. This position made the alphaA-crystallin-encoding gene (Cryaa) an excellent candidate gene. Sequence analysis revealed a mutation of a T to an A at position 371 in the Cryaa cDNA. The mutation was confirmed by an additional MnlI restriction site in the genomic DNA of homozygous mutants leading to replacement of Val with Glu at codon 124 affecting the C-terminal region of the alphaA-crystallin. CONCLUSIONS: The Aey7 mutant represents the first dominant mouse cataract mutation affecting the Cryaa gene. The mutation leads to progressive opacification of the lens. Compared with the beta- and gamma-crystallin-encoding genes, mutations in the alpha-crystallin-encoding genes are rare.


Subject(s)
Cataract/genetics , Crystallins/genetics , Point Mutation , Amino Acid Sequence , Animals , Base Sequence , Cataract/metabolism , Cataract/pathology , Chromosome Mapping , Chromosomes/genetics , Crystallins/metabolism , DNA Mutational Analysis , DNA Primers/chemistry , Female , Genes, Dominant , Genetic Linkage , Lens, Crystalline/metabolism , Lens, Crystalline/pathology , Male , Mice , Mice, Inbred C3H , Molecular Sequence Data , Polymerase Chain Reaction , Sequence Analysis, DNA
12.
Invest Ophthalmol Vis Sci ; 42(7): 1574-80, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11381063

ABSTRACT

PURPOSE: During an ethylnitrosourea (ENU) mutagenesis screen, mice were tested for the occurrence of dominant cataracts. One particular mutant was found that caused progressive opacity and was referred to as Aey2. The purpose of the study was to provide a morphologic description, to map the mutant gene, and to characterize the underlying molecular lesion. METHODS: Isolated lenses were photographed, and histologic sections of the eye were analyzed according to standard procedures. Linkage analysis was performed using a set of microsatellite markers covering all autosomal chromosomes. cDNA from candidate genes was amplified after reverse transcription of lens mRNA. RESULTS: The cortical opacification visible at eye opening progressed to an anterior suture cataract and reached its final phenotype as total opacity at 8 weeks of age. There was no obvious difference between heterozygous and homozygous mutants. The mutation was mapped to chromosome 5 proximal to the marker D5Mit138 (8.7 +/- 4.2 centimorgan [cM]) and distal to D5Mit15 (12.8 +/- 5.4 cM). No recombinations were observed to the markers D5Mit10 and D5Mit25. This position makes the genes within the betaA4/betaB-crystallin gene cluster excellent candidate genes. Sequence analysis revealed a mutation of T-->A at position 553 in the Crybb2 gene, leading to an exchange of Val for GLU: It affects the same region of the Crybb2 gene as in the Philly mouse. Correspondingly, the loss of the fourth Greek key motif is to be expected. CONCLUSIONS: The Aey2 mutant represents the second allele of Crybb2 in mice. Because an increasing number of beta- and gamma-crystallin mutations have been reported, a detailed phenotype-genotype correlation will allow a clearer functional understanding of beta- and gamma-crystallins.


Subject(s)
Cataract/genetics , Crystallins/genetics , Mutation , beta-Crystallin B Chain/analogs & derivatives , Alleles , Amino Acid Sequence , Animals , Base Sequence , Cataract/pathology , Chromosome Mapping , DNA Mutational Analysis , Genetic Linkage , Lens, Crystalline/pathology , Male , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Mutant Strains , Molecular Sequence Data , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid
13.
Curr Opin Genet Dev ; 11(3): 268-73, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11377962

ABSTRACT

A major challenge in post-genomics is the systematic determination of mammalian gene function. A variety of mouse mutagenesis technologies, both gene- and phenotype-driven, are being used to underpin systematic and comprehensive approaches to mammalian gene function studies. Recently, a number of centres have completed large-scale ENU mutagenesis programmes that employ a phenotype-driven approach to the generation of mouse mutants. The use of ENU mutagenesis represents a powerful and efficient approach to mammalian gene-function studies, but many parallel developments are needed in downstream technologies to properly harness the new enlarged mouse-mutant resources that are being created.


Subject(s)
Mice, Mutant Strains/genetics , Animals , Ethylnitrosourea , Genetic Variation , Humans , Mice , Mutagenesis , Phenotype
14.
Mamm Genome ; 12(4): 261-71, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11309656

ABSTRACT

Genetic factors strongly determine the outcome of infectious diseases caused by various pathogens. The molecular mechanisms of resistance and susceptibility in humans, however, remains largely unknown. Complex interactions of multiple genes that control the host response to a pathogen further complicate the picture. Animal models have a tremendous potential to dissect the complex genetic system of host-pathogen interaction into single components. This is particularly true for the mouse, which will continue to develop into an invaluable tool in the identification and cloning of host resistance genes. Three main approaches have been taken to establish mouse models for human infectious diseases: 1) Production of mouse mutants by gene targeting; 2) positional cloning of host-resistance genes in mutant mice; and 3) mapping and characterization of quantitative trait loci (QTL) controlling the complex aspects of host-pathogen interactions. The contribution of all three methods to the understanding of infectious diseases in humans will be reviewed in this work, with a special emphasis on the studies of resistance/susceptibility mechanism in bacterial infections.


Subject(s)
Bacteria/pathogenicity , Bacterial Infections/genetics , Animals , Apoptosis , Bacteria/genetics , Bacterial Infections/microbiology , Disease Models, Animal , Gene Expression , Genes, Bacterial , Genetic Predisposition to Disease , Genome , Humans , Immunity, Innate , Mice , Mice, Knockout , Quantitative Trait, Heritable , Virulence/genetics
15.
Int Arch Allergy Immunol ; 124(1-3): 25-8, 2001.
Article in English | MEDLINE | ID: mdl-11306917

ABSTRACT

BACKGROUND: The ENU Mouse Mutagenesis Project aims at a large-scale, systematic production of mouse mutants using the alkylating agent ethyl-nitrosourea (ENU). Offspring of mutagenized mice are subjected to a multiparameter screen to detect alterations in various phenotypes with the ultimate goal of identifying novel genes relevant for the expression of the phenotype. Using this approach, we have analyzed plasma IgE concentrations to identify mouse mutants with aberrant plasma IgE levels. METHODS AND RESULTS: ENU-mutagenized male C3HeB/FeJ were mated to wild-type females to produce F1 offspring. F1 animals were analyzed for alterations in their plasma IgE concentrations that showed a dominant mode of inheritance, or bred further to screen for recessive phenotypes. Plasma IgE concentrations were determined by ELISA and a normal range for plasma IgE was established using C3HeB/FeJ wild-type animals. So far we have tested 6568 F1 animals. Repeated testing confirmed a stable aberrant IgE phenotype in 124 animals. To confirm the genetic basis of the observed phenotype, these mice were subjected to confirmation crossing. Currently we have established 9 independent mutant mouse lines (3 with high plasma IgE and 6 with plasma IgE below detection limit) that have been genetically confirmed and additional 24 variant mouse lines are currently undergoing confirmation testing. CONCLUSION: ENU mouse mutagenesis allowed us to generate and identify mouse mutants with aberrant plasma IgE levels, which may be used to characterize novel genes involved in IgE regulation and may serve as animal models for IgE-mediated diseases.


Subject(s)
Disease Models, Animal , Hypersensitivity, Immediate/immunology , Immunoglobulin E/blood , Mice, Mutant Strains , Mutagenesis , Alkylating Agents , Animals , Ethylnitrosourea , Male , Mice , Phenotype
16.
Mamm Genome ; 12(3): 232-7, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11252173

ABSTRACT

As a first step towards the identification of cis-regulatory elements of Pax9 by means of comparative genomics, we have analyzed genome regions encompassing the Pax9 gene in three vertebrate species, humans, mice (Mus musculus), and the Japanese pufferfish (Fugu rubripes). We show the genomic organization of Pax9 and its physical association with Nkx2-9 conserved in the three species. We discuss about possible implications of the conserved synteny between Pax9 and Nkx2-9 in a context of vertebrate evolution. This report also includes the first description of the primary structures of Fugu Pax9 and Nkx2-9. Furthermore, we report the identification of a novel upstream exon and putative transcription start sites in mouse Pax9. Our results suggest that transcription of Pax9 may be initiated at two alternative start sites and driven by TATA-less promoters.


Subject(s)
DNA-Binding Proteins/genetics , Homeodomain Proteins/genetics , Transcription Factors/genetics , Amino Acid Sequence , Animals , Base Sequence , Binding Sites , Humans , Mice , Molecular Sequence Data , PAX9 Transcription Factor , Sequence Homology, Amino Acid , Transcription, Genetic , Zebrafish
18.
Proc Natl Acad Sci U S A ; 98(7): 3873-8, 2001 Mar 27.
Article in English | MEDLINE | ID: mdl-11259677

ABSTRACT

Within the mammalian inner ear there are six separate sensory regions that subserve the functions of hearing and balance, although how these sensory regions become specified remains unknown. Each sensory region is populated by two cell types, the mechanosensory hair cell and the supporting cell, which are arranged in a mosaic in which each hair cell is surrounded by supporting cells. The proposed mechanism for creating the sensory mosaic is lateral inhibition mediated by the Notch signaling pathway. However, one of the Notch ligands, Jagged1 (Jag1), does not show an expression pattern wholly consistent with a role in lateral inhibition, as it marks the sensory patches from very early in their development--presumably long before cells make their final fate decisions. It has been proposed that Jag1 has a role in specifying sensory versus nonsensory epithelium within the ear [Adam, J., Myat, A., Roux, I. L., Eddison, M., Henrique, D., Ish-Horowicz, D. & Lewis, J. (1998) Development (Cambridge, U.K.) 125, 4645--4654]. Here we provide experimental evidence that Notch signaling may be involved in specifying sensory regions by showing that a dominant mouse mutant headturner (Htu) contains a missense mutation in the Jag1 gene and displays missing posterior and sometimes anterior ampullae, structures that house the sensory cristae. Htu/+ mutants also demonstrate a significant reduction in the numbers of outer hair cells in the organ of Corti. Because lateral inhibition mediated by Notch predicts that disruptions in this pathway would lead to an increase in hair cells, we believe these data indicate an earlier role for Notch within the inner ear.


Subject(s)
Ear, Inner/growth & development , Membrane Proteins/metabolism , Proteins/physiology , Amino Acid Sequence , Animals , Calcium-Binding Proteins , Chromosome Mapping , Chromosomes , Ear, Inner/abnormalities , Homozygote , Humans , Intercellular Signaling Peptides and Proteins , Jagged-1 Protein , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Molecular Sequence Data , Mutation, Missense , Phenotype , Rats , Receptors, Notch , Sequence Analysis, DNA , Serrate-Jagged Proteins
19.
Genetics ; 157(3): 1313-20, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11238416

ABSTRACT

A novel ENU-induced mutation in the mouse leading to a nuclear and zonular opacity of the eye lens (Aey1) was mapped to chromosome 1 between the markers D1Mit303 and D1Mit332. On the basis of the chromosomal position, the gamma-crystallin encoding gene cluster (Cryg) and the betaA2-crystallin encoding gene Cryba2 were tested as candidate genes. An A --> T mutation destroys the start codon of the Cryge gene in the mutants; this mutation was confirmed by the absence of a restriction site for NcoI in the corresponding genomic fragment of homozygous mutants. The next in-frame start codon is 129 bp downstream; this predicted truncated gammaE-crystallin consists of 131 amino acids, resulting in a molecular mass of 14 kD. However, another open reading frame was observed just 19 bp downstream of the regular Cryge start codon, resulting in a protein of 119 amino acids and a calculated molecular weight of 13 kD. Western blot analysis using polyclonal antibodies against gamma-crystallins or the novel Aey1-specific protein demonstrated the specific expression of the Aey1 protein in the cataractous lenses only; the truncated form of the gammaE-crystallin could not be detected. Therefore, it is concluded that the novel protein destroys the sensitive cellular structure of the eye lens.


Subject(s)
Cataract/chemically induced , Cataract/genetics , Eye/metabolism , Mutagens , Mutation , Amino Acid Sequence , Animals , Base Sequence , Blotting, Western , Codon , Crosses, Genetic , Crystallins/genetics , Electrophoresis, Polyacrylamide Gel , Female , Genetic Markers , Haplotypes , Lens, Crystalline/pathology , Male , Mice , Models, Genetic , Molecular Sequence Data , Open Reading Frames , Polymerase Chain Reaction , Sequence Homology, Nucleic Acid , Software
20.
Exp Eye Res ; 73(6): 867-76, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11846517

ABSTRACT

During an ethylnitrosourea mutagenesis screen, Aey5, a new mouse mutation exhibiting an autosomal dominant congenital cataract was isolated. The cataractous phenotype is visible at the eye opening and progresses to a nuclear and zonular cataract at 2 months of age with no difference in onset or severity between heterozygous and homozygous mutants. Histological analysis revealed that fiber cell differentiation continues at the lens bow region, but the cell nuclei do not degrade normally and remain in the deeper cortex. Further, the lens nucleus has clefts of various sizes while the remainder of the eye was morphologically normal. The mutation was mapped to chromosome 3 between the markers D3Mit101 and D3Mit77 near the connexin encoding genes Gja5 and Gja8. Sequence analysis revealed no differences in the Gja5 gene, but identified a T-->C mutation at position 191 in the Gja8 gene, which was confirmed by an additional Mva 12691 restriction site in the genomic DNA of homozygous mutants. This mutation results in Val-->Ala substitution at codon 64 of connexin50 (Cx50) also known as lens membrane protein 70 (MP70). Aey5 represents the second dominant mouse cataract mutant affecting Cx50, a membrane protein preferentially expressed in the lens. Since both mutations affect similar regions in the first extracellular domain this region appears to be critically important for its function in lens transparency.


Subject(s)
Cataract/genetics , Crystallins/genetics , Mutation/genetics , Animals , Female , Genes, Dominant , Male , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Phenotype , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...